SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-028164
Filing Date
2022-11-03
Accepted
2022-11-03 16:00:17
Documents
57
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crdf-20220930.htm   iXBRL 10-Q 1317107
2 EX-31.1 crdf-093022exhibit311.htm EX-31.1 10820
3 EX-31.2 crdf-093022exhibit312.htm EX-31.2 10790
4 EX-32.1 crdf-093022exhibit321.htm EX-32.1 6228
5 EX-32.2 crdf-093022exhibit322.htm EX-32.2 6198
  Complete submission text file 0001628280-22-028164.txt   5690399

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crdf-20220930.xsd EX-101.SCH 32137
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crdf-20220930_cal.xml EX-101.CAL 74187
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crdf-20220930_def.xml EX-101.DEF 123022
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crdf-20220930_lab.xml EX-101.LAB 442347
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crdf-20220930_pre.xml EX-101.PRE 267063
51 EXTRACTED XBRL INSTANCE DOCUMENT crdf-20220930_htm.xml XML 1112180
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35558 | Film No.: 221357785
SIC: 2836 Biological Products, (No Diagnostic Substances)